clinical trials

AstraZeneca Plc (NYSE: AZN) CEO Pascal Soriot said during a conference call with investors Wednesday that a person experiencing symptoms related to a rare neurological disorder caused its global COVID-19 vaccine trials to pause, Stat reported.  What Happened: Soriot revealed...

Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline PLC (NYSE: GSK) on Thursday announced they had started the early-stage clincial trials for for their COVID-19 vaccine candidate the same day. What Happened: This untested vaccine is made by blending the technology used in Sanofi’s seasonal...

Sanofi SA (NASDAQ: SNY) announced Tuesday that its rheumatoid arthritis drug Kevzara, developed in partnership with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), isn't effective against COVID-19. What Happened: The global Phase 3 trial involving the administration of the...

AstraZeneca Plc (NYSE: AZN) announced Monday that its COVID-19 vaccine candidate is moving into phase three clinical trials for all adult age groups in the United States. What Happened:  The development of AZD1222 is already in the late stages of testing in the United...

Swiss pharmaceutical company Novartis AG (NYSE: NVS) announced Saturday that the phase three COMBI-i trial for a combination of drugs against a type of advanced skin cancer didn't meet the clinical requirements of the evaluation. What Happened: The study was a randomized, double-blind...

Poseida Therapeutics Inc. (NASDAQ: PSTX) stock dropped about 34.5% in the after-hours trading on Monday, after a patient died in a prostate cancer drug trial, according to a filing the company made with the United States Securities and Exchange Commission. What Happened The trial was carried out in...

Drug research is a long process that is loaded with a huge inherent risk. With opposition to animal testing rising and the data it generates being less than perfect, a via-media mode of testing done using live human skin models is slowly and steadily gaining acceptance among pharma and...

Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) have reached an agreement with the United Kingdom to supply up to 60 million doses of their jointly-developed coronavirus vaccine, the two drugmakers announced Wednesday. What Happened A regulatory approval for the vaccine...

The Last Week In A Nutshell What Happened: “The S&P 500 is up 1.3% month-to-date (through June 25), but has struggled to push higher as it moves towards its previous peak,” said Lindsey Bell, chief investment strategist for Ally Financial, Inc-owned (NYSE: ALLY) Ally Invest. “...

Biotech Proteostasis Therapeutics Inc. (NASDAQ: PTI) develops therapeutics for the treatment of cystic fibrosis and associated disorders. The company’s lead product candidates are PTI-801 and PTI-808. What Happened Proteostasis shares were surging 300 percent on the announcement of positive...

Shares of Axovant Sciences Ltd (NASDAQ: AXON) plummeted more than 70 percent after the company's late-stage trial involving its therapy for the treatment of Alzheimer's failed to meet its primary objectives in a phase 3 study called MINDSET. Investors thinking Axovant's stock can't see any...

It turns out you can have too much of a good thing. The 1,000-plus immunotherapy trials and competition to develop proprietary versions of virtually the same drugs may prove inhibitory to cancer research, according to the New York Times. The conditions leave clinical researchers competing for the...

Shares of Opko Health Inc. (NASDAQ: OPK), a pharmaceutical and diagnostics company, plunged more than 15 percent on Friday after the company reported disappointing results to a clinical trial. In a press release, Opko Health announced data analysis from a Phase 3 trial which evaluated its long-...

Pharmaceutical companies are naturally in the business of selling a drug or therapy to patients suffering from an illness in disease. The process is often lengthy, expensive and could result in companies declaring bankruptcies — or reaping hundreds of millions of dollars in profit. For very...